Article
Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).
PloS one - 1 Jan 2017
Dold Leona, Luda Carolin, Schwarze-Zander Carolynne, Boesecke Christoph, Hansel Cordula, Nischalke Hans-Dieter, Lutz Philipp, Mohr Raphael, Wasmuth Jan-Christian, Strassburg Christian P, Trebicka Jonel, Rockstroh Jürgen Kurt, Spengler Ulrich
Abstract excerpt
Hepatic steatosis can occur with any antiretroviral therapy (cART). Although single nucleotide polymorphisms (SNPs) have been identified to predispose to alcoholic and non-alcoholic fatty liver disease, their role for treatment-associated steatosis in HIV-positive patients remains unclear. We determined the frequency of PNPLA3 (rs738409), CSPG3/NCAN (rs2228603), GCKR (rs780094), PPP1R3B (rs4240624), TM6SF...
Read the complete abstract on PubMed